Merus Labs International Inc (MSLI.OQ) Quote| Reuters.com
Edition:
United States

Merus Labs International Inc (MSLI.OQ)

MSLI.OQ on NASDAQ Stock Exchange Capital Market

1.21USD
24 Jun 2016
Change (% chg)

$-0.06 (-4.72%)
Prev Close
$1.27
Open
$1.18
Day's High
$1.21
Day's Low
$1.18
Volume
4,403
Avg. Vol
2,621
52-wk High
$2.63
52-wk Low
$1.08

MSLI.OQ

Chart for MSLI.OQ

About

Merus Labs International Inc. (Merus) is a specialty pharmaceutical company. The Company is engaged in the acquisition and licensing of branded prescription pharmaceutical products in Canada and internationally. It carries out business principally in Canada and Europe. The Company has products in the area of urology/women's... (more)

Overall

Beta: 1.45
Market Cap(Mil.): $123.90
Shares Outstanding(Mil.): 102.60
Dividend: --
Yield (%): --

Financials

  MSLI.OQ Industry Sector
P/E (TTM): -- 32.69 34.11
EPS (TTM): -0.05 -- --
ROI: -2.57 15.00 14.23
ROE: -4.31 16.08 15.46

BRIEF-Merus Labs reports fiscal Q2 2016 results

* Qtrly net revenue of $19.7 million, a 55 pct increase over Q2 2015

May 11 2016

BRIEF-Merus announces first patient dosed in Phase 1/2 trial

* Announces first patient dosed in Phase 1/2 trial evaluating bispecific antibody candidate mcLA-17 in patients with AML Source text for Eikon: (Bengaluru Newsroom: +1 646 223 8780)

May 04 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Wright Reports
$75.00
Provider : ValuEngine, Inc.
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.